Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...
FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...
While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects.
She lost 7 pounds in her best week on the shots. With all her experience, Jordan knows how to troubleshoot common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback